Alkem Laboratories Limited (ALKEM.BO)
INR 5510.8
(0.46%)
INR 5510.8
(0.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 155.74 Billion INR | 13.22% |
| 2022 | 137.56 Billion INR | -2.22% |
| 2021 | 140.69 Billion INR | 22.14% |
| 2020 | 115.19 Billion INR | 15.85% |
| 2019 | 99.43 Billion INR | 21.14% |
| 2018 | 82.08 Billion INR | 7.08% |
| 2017 | 76.65 Billion INR | 16.71% |
| 2016 | 65.68 Billion INR | 20.77% |
| 2015 | 54.38 Billion INR | 2.7% |
| 2014 | 52.95 Billion INR | 25.13% |
| 2013 | 42.32 Billion INR | 4.54% |
| 2012 | 40.48 Billion INR | 27.21% |
| 2011 | 31.82 Billion INR | 19.94% |
| 2010 | 26.53 Billion INR | 70.16% |
| 2009 | 15.59 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 155.74 Billion INR | 13.22% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 149.25 Billion INR | 0.0% |
| 2023 Q4 | 155.74 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 137.56 Billion INR | -2.22% |
| 2022 Q4 | 137.56 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 138.69 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q2 | 126.79 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 140.69 Billion INR | 22.14% |
| 2021 Q4 | 140.69 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 115.19 Billion INR | 0.0% |
| 2020 Q2 | 105.41 Billion INR | 0.0% |
| 2020 FY | 115.19 Billion INR | 15.85% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 99.43 Billion INR | 0.0% |
| 2019 Q2 | 91.54 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 99.43 Billion INR | 21.14% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 82.08 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 82.08 Billion INR | 7.08% |
| 2018 Q2 | 78.71 Billion INR | 0.0% |
| 2017 Q4 | 76.65 Billion INR | 0.0% |
| 2017 FY | 76.65 Billion INR | 16.71% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 73.33 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 65.68 Billion INR | 20.77% |
| 2016 Q2 | 63.69 Billion INR | 0.0% |
| 2016 Q4 | 65.68 Billion INR | 0.0% |
| 2015 Q2 | 55.96 Billion INR | 0.0% |
| 2015 Q4 | 54.38 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 54.38 Billion INR | 2.7% |
| 2014 Q4 | 52.95 Billion INR | 0.0% |
| 2014 FY | 52.95 Billion INR | 25.13% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 42.32 Billion INR | 4.54% |
| 2012 FY | 40.48 Billion INR | 27.21% |
| 2011 FY | 31.82 Billion INR | 19.94% |
| 2010 FY | 26.53 Billion INR | 70.16% |
| 2009 FY | 15.59 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | -235.782% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -4145.338% |
| Sigachi Industries Limited | 6.94 Billion INR | -2143.716% |
| Bal Pharma Limited | 3.2 Billion INR | -4761.247% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -1236.779% |
| Medico Remedies Limited | 961.95 Million INR | -16090.916% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -10223.48% |
| Venus Remedies Limited | 6.26 Billion INR | -2384.709% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -2924.018% |
| Alpa Laboratories Limited | 1.82 Billion INR | -8428.505% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -610.84% |
| Shilpa Medicare Limited | 30.93 Billion INR | -403.52% |
| Aarti Drugs Limited | 24.32 Billion INR | -540.321% |
| Lupin Limited | 239.97 Billion INR | 35.097% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 65.444% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 46.808% |
| Windlas Biotech Limited | 6.26 Billion INR | -2387.185% |
| Suven Life Sciences Limited | 2.84 Billion INR | -5366.744% |
| Eris Lifesciences Limited | 70.48 Billion INR | -120.957% |
| Valiant Laboratories Limited | 3.42 Billion INR | -4444.931% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -289.945% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -562.491% |
| Ipca Laboratories Limited | 111.01 Billion INR | -40.298% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -1183.08% |
| Achyut Healthcare Limited | 309.52 Million INR | -50219.202% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 81.776% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -1935.595% |
| RPG Life Sciences Limited | 5.12 Billion INR | -2936.812% |
| Mankind Pharma Limited | 119.63 Billion INR | -30.189% |
| Laurus Labs Limited | 83.87 Billion INR | -85.702% |
| Piramal Pharma Limited | 153.11 Billion INR | -1.718% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -3748.848% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | -3.412% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -141.637% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | -8.471% |
| Unichem Laboratories Limited | 31.69 Billion INR | -391.423% |
| Sequent Scientific Limited | 15.4 Billion INR | -911.105% |
| Novartis India Limited | 9.24 Billion INR | -1583.9% |
| Wanbury Limited | 3.43 Billion INR | -4434.269% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -590.963% |
| Wockhardt Limited | 76.49 Billion INR | -103.62% |
| Themis Medicare Limited | 5.66 Billion INR | -2649.726% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -7074.794% |
| Jubilant Pharmova Limited | 115.48 Billion INR | -34.865% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -446.409% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 59.809% |
| Divi's Laboratories Limited | 154.7 Billion INR | -0.678% |
| NATCO Pharma Limited | 69.06 Billion INR | -125.517% |
| Gufic Biosciences Limited | 10.92 Billion INR | -1325.566% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -593.945% |
| Ind-Swift Limited | 6.54 Billion INR | -2279.768% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -1860.685% |
| FDC Limited | 24.68 Billion INR | -531.051% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -8641.365% |
| Granules India Limited | 55.2 Billion INR | -182.104% |
| Medicamen Biotech Limited | 2.94 Billion INR | -5188.189% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -1344.758% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -32979.879% |
| Brooks Laboratories Limited | 904.45 Million INR | -17120.223% |
| Megasoft Limited | 3.65 Billion INR | -4156.604% |
| ZIM Laboratories Limited | 4.46 Billion INR | -3385.703% |
| Strides Pharma Science Limited | 58.39 Billion INR | -166.705% |
| Neuland Laboratories Limited | 18.32 Billion INR | -749.898% |
| Morepen Laboratories Limited | 12.93 Billion INR | -1104.364% |
| Hikal Limited | 24.87 Billion INR | -526.217% |
| Indoco Remedies Limited | 21.44 Billion INR | -626.194% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -503.187% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -6387.876% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -4571.197% |
| Hester Biosciences Limited | 6.62 Billion INR | -2251.471% |